What the research found

Research tracing the origin of fat in the liver reveals three distinct sources feeding the accumulation. Using isotope labeling, researchers followed where hepatic fat actually originates: roughly 59% comes from circulating fatty acids released by adipose tissue (especially pronounced when insulin resistance is present), approximately 26% is synthesized de novo within the liver itself from glucose and fructose, and about 15% arrives directly from dietary fat. The metabolic distinction matters significantly—in people with fatty liver disease, the rate of internal fat synthesis runs more than three times faster than in those with healthy livers, and critically, this synthesis loses its normal fasting-fed rhythm, operating continuously rather than rising and falling with meal timing.

The source of fat determines intervention targets. The fructose contribution is mechanistically different from whole-food sources: fructose consumed rapidly and in isolation (juice, soda, processed foods) overwhelms the intestinal fructose-processing capacity and floods the liver, whereas fructose embedded in whole fruit is processed gradually by the small intestine, with approximately 90% cleared before reaching the portal circulation.

Why it matters for you

If you're tracking lipid profiles or liver enzymes (AST, ALT, GGT), understanding the fat accumulation mechanism helps explain why your labs may not improve with dietary fat restriction alone. The 26% of hepatic fat synthesized on-site suggests that carbohydrate quality and meal timing matter as much as total fat intake. Specifically: controlling glucose and fructose spikes—particularly the continuous fructose exposure from processed foods and liquid sugars—addresses the "factory that lost its off switch." This points to practical interventions: monitoring fasting periods to allow hepatic fat synthesis to normalize its rhythm, and prioritizing whole-food carbohydrate sources over refined sugars and juices.

The insulin resistance component (driving the 59% contribution from adipose tissue) is where many MyKine users have leverage. Weight loss, improved insulin sensitivity through training, and reduced fasting glucose all directly narrow the "sewer line" supplying fatty acids to the liver. Fibrosis can reverse, meaning early detection and intervention via biomarkers (FIB-4 score, elastography if available) creates a window for meaningful improvement before permanent scarring occurs.

Caveats

• The isotope tracer study measured fat sources at a single timepoint; longitudinal or seasonal variation isn't addressed
• Animal research on intestinal fructose clearance (the 90% figure) may not translate uniformly to humans across different populations
• The article doesn't quantify how quickly fibrosis reverses or what degree of reversal is typical
• No effect sizes or confidence intervals provided for the three fat source percentages
• The comparison of de novo lipogenesis rates between fatty and normal livers lacks sample size and statistical detail